Prevention of amputation by neoadjuvant therapy with pembrolizumab in acrolentiginous melanoma
Journal of the European Academy of Dermatology and Venereology · 2024
DOI: 10.1111/jdv.19920 ↗Kurz gefasst
Leserbrief in der Zeitschrift Journal of the European Academy of Dermatology and Venereology, 2024. Verfasst von Inga Hansen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology and Venereology, University Skin Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. Hauptthemen laut MEDLINE: Amputation, Surgical, Antibodies, Monoclonal, Humanized, Melanoma, Neoadjuvant Therapy. Die Arbeit nennt 10 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Dermatology and Venereology, University Skin Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
- Institute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
ORCID-Profile: Glenn Geidel, Julian Kött, Christoffer Gebhardt
Zitieren
APA
Hansen, I., Rünger, A., Noebel, C., Geidel, G., Kött, J., Menz, A., Hildebrandt, L., Schneider, S. W., & Gebhardt, C. (2024). Prevention of amputation by neoadjuvant therapy with pembrolizumab in acrolentiginous melanoma. Journal of the European Academy of Dermatology and Venereology. https://doi.org/10.1111/jdv.19920
Vancouver
Hansen I, Rünger A, Noebel C, Geidel G, Kött J, Menz A, et al. Prevention of amputation by neoadjuvant therapy with pembrolizumab in acrolentiginous melanoma. Journal of the European Academy of Dermatology and Venereology. 2024. doi:10.1111/jdv.19920
BibTeX
@article{Hansen2024,
author = {Hansen, Inga and Rünger, Alessandra and Noebel, Clara and Geidel, Glenn and Kött, Julian and Menz, Anne and Hildebrandt, Lina and Schneider, Stefan W and Gebhardt, Christoffer},
title = {Prevention of amputation by neoadjuvant therapy with pembrolizumab in acrolentiginous melanoma},
journal = {Journal of the European Academy of Dermatology and Venereology},
year = {2024},
doi = {10.1111/jdv.19920}
}
EUVIMED